ZA200805354B - Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives - Google Patents

Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives

Info

Publication number
ZA200805354B
ZA200805354B ZA200805354A ZA200805354A ZA200805354B ZA 200805354 B ZA200805354 B ZA 200805354B ZA 200805354 A ZA200805354 A ZA 200805354A ZA 200805354 A ZA200805354 A ZA 200805354A ZA 200805354 B ZA200805354 B ZA 200805354B
Authority
ZA
South Africa
Prior art keywords
isoxazol
imidazo
aryl
pyridine derivatives
pyridine
Prior art date
Application number
ZA200805354A
Other languages
English (en)
Inventor
Buettelmann Bernd
Dong Jiaqiang
Han Bo
Knust Henner
Thomas Andrew
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200805354B publication Critical patent/ZA200805354B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200805354A 2005-12-27 2008-06-19 Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives ZA200805354B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05112988 2005-12-27

Publications (1)

Publication Number Publication Date
ZA200805354B true ZA200805354B (en) 2009-10-28

Family

ID=37909303

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805354A ZA200805354B (en) 2005-12-27 2008-06-19 Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives

Country Status (17)

Country Link
US (1) US7399769B2 (de)
EP (1) EP1968977B1 (de)
JP (1) JP4864982B2 (de)
KR (1) KR101033719B1 (de)
CN (1) CN101346377B (de)
AR (1) AR058728A1 (de)
AT (1) ATE537171T1 (de)
AU (1) AU2006331363B2 (de)
BR (1) BRPI0620760A2 (de)
CA (1) CA2633536A1 (de)
ES (1) ES2376357T3 (de)
IL (1) IL192236A0 (de)
NO (1) NO20082748L (de)
RU (1) RU2420527C2 (de)
TW (1) TWI324156B (de)
WO (1) WO2007074089A1 (de)
ZA (1) ZA200805354B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1968973T3 (da) * 2005-12-27 2011-10-31 Hoffmann La Roche Aryl-isoxazol-4-yl-imidazolderivater
ES2369805T3 (es) 2007-06-22 2011-12-07 F. Hoffmann-La Roche Ag Derivados de isoxazol-imidazol.
DK2767536T3 (en) 2007-12-04 2015-10-19 Hoffmann La Roche Isoxazolo-pyridine derivatives
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
RU2014149123A (ru) 2012-06-26 2016-08-20 Саниона Апс Фенилтриазольное производное и его применение для модуляции ГАМКА-рецепторного комплекса
WO2014001278A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2014001280A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
CN104411699B (zh) 2012-06-26 2017-06-13 萨尼奥纳有限责任公司 苯基三唑衍生物及其用于调节gabaa 受体复合体的用途
WO2014001279A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
LT3105226T (lt) 2014-02-13 2019-11-11 Incyte Corp Ciklopropilaminai, kaip lsd1 inhibitoriai
PL3105218T3 (pl) 2014-02-13 2020-03-31 Incyte Corporation Cyklopropyloaminy jako inhibitory lsd1
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
EP3277689B1 (de) 2015-04-03 2019-09-04 Incyte Corporation Heterocyclische verbindungen als lsd1-hemmer
SG10202001219UA (en) 2015-08-12 2020-03-30 Incyte Corp Salts of an lsd1 inhibitor
BR102019014802A2 (pt) 2018-07-20 2020-02-04 Boehringer Ingelheim Int difluorometil-fenil triazóis
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511987B1 (en) * 1999-11-12 2003-01-28 Neurogen Corporation Bicyclic and tricyclic heteroaromatic compounds
AU2002353844A1 (en) * 2001-11-20 2003-06-10 Eli Lilly And Company Beta 3 adrenergic agonists

Also Published As

Publication number Publication date
AR058728A1 (es) 2008-02-20
ATE537171T1 (de) 2011-12-15
AU2006331363B2 (en) 2012-07-05
IL192236A0 (en) 2008-12-29
NO20082748L (no) 2008-09-24
JP4864982B2 (ja) 2012-02-01
TW200734328A (en) 2007-09-16
ES2376357T3 (es) 2012-03-13
EP1968977B1 (de) 2011-12-14
EP1968977A1 (de) 2008-09-17
US20070191421A1 (en) 2007-08-16
JP2009521517A (ja) 2009-06-04
CN101346377A (zh) 2009-01-14
WO2007074089A1 (en) 2007-07-05
TWI324156B (en) 2010-05-01
CA2633536A1 (en) 2007-07-05
RU2008125040A (ru) 2010-02-10
AU2006331363A1 (en) 2007-07-05
BRPI0620760A2 (pt) 2011-11-22
US7399769B2 (en) 2008-07-15
KR101033719B1 (ko) 2011-05-09
RU2420527C2 (ru) 2011-06-10
CN101346377B (zh) 2011-05-11
KR20080072072A (ko) 2008-08-05

Similar Documents

Publication Publication Date Title
ZA200805354B (en) Aryl-isoxazol-4-yl-imidazo[1,5-A]pyridine derivatives
HUS1900034I1 (hu) 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok
ZA200703912B (en) 3-arylamino pyridine derivatives
ZA201202026B (en) PYROLO[2,3-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
AP2007003887A0 (en) Pyridine derivatives
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
EP1741703A4 (de) Pyridonderivat
ZA200808283B (en) Pyridine[3,4-B]pyrazinones
IL180481A0 (en) Aryl-pyridine derivatives
IL179736A0 (en) Pyrrazolo-pyrimidine derivatives
IL177968A0 (en) Tetrahydropyridoindole derivatives
EP1820797A4 (de) Substituiertes pyridonderivat
IL183140A0 (en) Substituted benzoquinolizine derivatives
IL195915A0 (en) 3-amino -imidazo[1,2-a]pyridine derivatives as sglt inhibitors
IL198239A0 (en) Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a] pyrimidin -6- one and 8-piperidinyl-2- pyrimidinyl [1,2-a] pyrimidin -6- one derivatives
HK1100002A1 (en) 4-phenyl-pyrimidine-2-carbonitrile derivatives
HK1100775A1 (en) 4-Amino-5-cyanopyrimidine derivatives
GB0414272D0 (en) OsK1 derivatives
IL190989A0 (en) Thiazolo [4,5-c]pyridine derivatives
IL182538A0 (en) 1,5-diheterocycle-1h-triazole derivative
IL182001A0 (en) 2-acylaminothiazole derivatives
IL188111A0 (en) 2,5-bis-diamimne [1,4] benzoquinone-derivatives
EP1711189A4 (de) 6,11-3c-bicyclische 8a-azalid-derivate
HK1164868A1 (en) Substituted pyridine derivatives
EP1873154A4 (de) Pyrazolo[1,5-a]pyridinderivat oder medizinisch annehmbares salz davon